For the Inventor, By the Inventor

Enter inventor name

Macquarie Park, Australia

Adam Clarke

USPTO Granted Patents = 24 (Patent Applications = 12)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 44(Granted Patents)

Location History:

Five Dock, AU (2013 - 2021)
Sydney, AU (2021)
Riverstone, AU (2023)
Macquarie Park, AU (2014 - 2024)

Company Filing History:

Teva Pharmaceuticals Australia Pty Ltd

Cephalon Australia Pty. Ltd.

4. 1 out of 1,012

National Research Council of Canada

Teva Pharmaceuticals Ausralia Pty Ltd

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410256 - Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases (2025-09-09),

2. 12410247 - Polynucleotides encoding antibodies that specifically bind to human IL-15 (2025-09-09),

3. 12384841 - Anti-PAR-2 antibodies and methods of use thereof (2025-08-12),

4. 12358980 - Compositions and methods for anti-PACAP antibodies (2025-07-15),

5. 12162946 - Antibodies that specifically bind to TL1A and methods of treating gastrointestinal disease (2024-12-10),

6. 12018084 - Anti-CXCR2 antibodies and uses thereof (2024-06-25),

7. 11725052 - Anti-PAR-2 antibodies and methods of use thereof (2023-08-15),

8. 11332534 - Anti-CXCR2 antibodies and uses thereof (2022-05-17),

9. 11319356 - Interferon alpha 2B variants (2022-05-03),

10. 11267883 - Antibodies that specifically bind to human IL-15 and uses thereof (2022-03-08),

11. 11220549 - Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases (2022-01-11),

12. 11117975 - Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B (2021-09-14),

13. 11111292 - Anti-IL-5 antibodies (2021-09-07),

14. 10981986 - Fusions of antibodies to CD38 and attenuated interferon alpha (2021-04-20),

15. 10906973 - Antibody variants transmigrating the blood-brain barrier and uses thereof (2021-02-02),

Title: Inventor Adam Clarke - Revolutionizing Technology in Macquarie Park, AU

Introduction: Adam Clarke is a visionary inventor based in Macquarie Park, AU, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Adam Clarke holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Adam Clarke has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Adam Clarke has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and creativity in all his projects.

Conclusion: Adam Clarke's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs in Macquarie Park, AU, and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…